Cayre Y, Raynal M C, Darzynkiewicz Z, Dorner M H
Program in Immunology, Memorial Sloan-Kettering Cancer Center, Cornell University Graduate School of Medical Sciences, New York, NY 10021.
Proc Natl Acad Sci U S A. 1987 Nov;84(21):7619-23. doi: 10.1073/pnas.84.21.7619.
A mature hematopoietic cell represents the end product of a stepwise differentiation process. As a model system for studying differentiation, the human promyelocytic leukemia cell line HL-60 undergoes terminal monocytic/macrophagic differentiation following exposure to either phorbol 12-myristate 13-acetate or 1,25-dihydroxyvitamin D3. We have derived and analyzed a variant HL-60 cell line, 1F10, that permits the study of several intermediate steps in the myeloid differentiation process. These intermediate steps are documented by cell cycle data and phenotype analysis as well as markers such as c-myc, c-fms, and both subunits of ferritin.
成熟的造血细胞是逐步分化过程的最终产物。作为研究分化的模型系统,人早幼粒细胞白血病细胞系HL-60在暴露于佛波酯12-肉豆蔻酸酯13-乙酸酯或1,25-二羟基维生素D3后会经历终末单核细胞/巨噬细胞分化。我们已经衍生并分析了一种变体HL-60细胞系1F10,它可用于研究髓系分化过程中的几个中间步骤。这些中间步骤通过细胞周期数据、表型分析以及诸如c-myc、c-fms和铁蛋白的两个亚基等标志物得以记录。